YKL-40 is highly expressed in reactivated astrocytes, where it is proposed to mediate the effects of hyperphosphorylated tau in Alzheimer’s disease preclinical models [183]. Here, CHI3L1 is linked to early-onset autosomal dominant Alzheimer disease.